Caffeine antagonizes diazepam effects in man. 1982

M J Mattila, and E Palva, and K Savolainen

In a double-blind, placebo-controlled study on parallel groups of medical students diazepam 10 mg impaired cognitive skills and caused muscle relaxation. A 250 mg dose of caffeine given in decaffeinated coffee counteracted these better than a 500 mg dose. Subjectively, diazepam exerted a calming effect which was counteracted by caffeine at either at either dose levels.

UI MeSH Term Description Entries
D008297 Male Males
D008606 Mental Processes Conceptual functions or thinking in all its forms. Information Processing, Human,Human Information Processing
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009126 Muscle Relaxation That phase of a muscle twitch during which a muscle returns to a resting position. Muscle Relaxations,Relaxation, Muscle,Relaxations, Muscle
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

M J Mattila, and E Palva, and K Savolainen
May 1981, Life sciences,
M J Mattila, and E Palva, and K Savolainen
January 1983, Medical biology,
M J Mattila, and E Palva, and K Savolainen
April 1983, British journal of anaesthesia,
M J Mattila, and E Palva, and K Savolainen
April 1994, Pharmacology, biochemistry, and behavior,
M J Mattila, and E Palva, and K Savolainen
January 1980, Psychopharmacology,
M J Mattila, and E Palva, and K Savolainen
June 1984, Life sciences,
M J Mattila, and E Palva, and K Savolainen
February 1970, Nutrition reviews,
M J Mattila, and E Palva, and K Savolainen
January 1993, Pharmacology & toxicology,
M J Mattila, and E Palva, and K Savolainen
January 1983, European journal of clinical pharmacology,
M J Mattila, and E Palva, and K Savolainen
October 1979, Activitas nervosa superior,
Copied contents to your clipboard!